Walton Thomas Layton 13D and 13G filings for Finch Therapeutics Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:59 pm Sale |
2021-12-31 | 13G | Finch Therapeutics Group, Inc. FNCH |
Walton Thomas Layton | 0 0.000% |
-116,239 (Position Closed) |
Filing |
| 2021-03-26 4:47 pm Purchase |
2021-03-23 | 13G | Finch Therapeutics Group, Inc. FNCH |
Walton Thomas Layton | 116,239 7.400% |
116,239 (New Position) |
Filing |